Tongfang Kontafarma Holdings Limited (1312.HK) HKSE

0.03

-0.001(-3.23%)

Updated at August 18 03:59PM

Currency In HKD

Tongfang Kontafarma Holdings Limited

Address

Sun Hung Kai Centre

Wan Chai,

Hong Kong

Phone

852 2731 6500

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

714

First IPO Date

January 18, 2012

Key Executives

NameTitlePayYear Born
Ms. Zixiu GuoFinancial Controller & Executive Director105,000N/A
Mr. Jiankun LiuExecutive Director0N/A
Mr. Feifei WangExecutive Chairman & President0N/A
Ms. Linna QiaoVice President & Executive Director0N/A
Mr. Jie ZhangChief Operating Officer0N/A
Ms. Lok Tung ChanCompany Secretary0N/A

Description

Tongfang Kontafarma Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States. The company operates in Pharmaceutical Business and Fitness Business segments. It also offers chemical drugs and prescribed traditional Chinese medicines; operates fitness centers; operates in the franchise business; and provides consultation services for fitness and health activities. The company trades in laboratory related products; researches and develops medical products; and offers corporate advisory services. As of December 31, 2021, it operated 12 fitness centers and 2 yoga center in Taiwan; and 10 fitness centers in Singapore. The company was formerly known as Allied Cement Holdings Limited and changed its name to Tongfang Kontafarma Holdings Limited in August 2016. The company was founded in 1993 and is headquartered in Wan Chai, Hong Kong. Tongfang Kontafarma Holdings Limited is a subsidiary of China Health Management Investment Limited.